Novartis reports Zolgensma caused two deaths from liver failureTherapeuticsThe two fatal cases of acute liver failure took place in Russia and Kazakhstan after 5 to 6 weeks of Zolgensma infusion and about 1-10 days following the initiation of corticosteroid taper, according to the company. Read more August 11, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersHealthNovartisbuilding.webp 729 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-08-11 17:31:102022-08-12 08:09:18Novartis reports Zolgensma caused two deaths from liver failure